Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Kahn

Showing results (11-20 of 136) with videos related to

Pageof 14
Sort By:
Translational Respiratory Medicine|December 16, 2014
Inhibition of β-catenin/p300 interaction proximalizes mouse embryonic lung epitheliumTomoyo Sasaki, Michael Kahn
Current Molecular Pharmacology|April 12, 2014
Hypoxia selects for a quiescent, CML stem/leukemia initiating-like population dependent on CBP/catenin transcriptionAiko Kida, Michael Kahn
South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde|March 20, 2008
Pharmacologically active: clinical trials and the pharmaceutical industryMichael Kahn, Michael Gastrow
Mini Reviews in Medicinal Chemistry|October 9, 2002
Design, synthesis, and application of peptide secondary structure mimeticsMasakatsu Eguchi, Michael Kahn
Drug Discovery Today|October 26, 2005
Investigating Wnt signaling: a chemogenomic safariMichael McMillan, Michael Kahn
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 10, 2010
Targeting Wnt signaling: can we safely eradicate cancer stem cells?Fumi Takahashi-Yanaga, Michael Kahn
Advanced Drug Delivery Reviews|October 6, 2010
The Wnt signaling pathway in cellular proliferation and differentiation: A tale of two coactivatorsJia-Ling Teo, Michael Kahn
Cancer Science|July 1, 2014
Safely targeting cancer stem cells via selective catenin coactivator antagonismHeinz-Josef Lenz, Michael Kahn
Cell Biology and Toxicology|March 24, 2016
Kat3 coactivators in somatic stem cells and cancer stem cells: biological roles, evolution, and pharmacologic manipulationPaul D Thomas, Michael Kahn
Research and Reports in Biochemistry|November 14, 2015
The role of the Wnt signaling pathway in cancer stem cells: prospects for drug developmentYong-Mi Kim, Michael Kahn
Pageof 14

Showing results (11-20 of 136) with videos related to

Sort By:
Pageof 14
Translational Respiratory Medicine|December 16, 2014
Inhibition of β-catenin/p300 interaction proximalizes mouse embryonic lung epitheliumTomoyo Sasaki, Michael Kahn
Current Molecular Pharmacology|April 12, 2014
Hypoxia selects for a quiescent, CML stem/leukemia initiating-like population dependent on CBP/catenin transcriptionAiko Kida, Michael Kahn
South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde|March 20, 2008
Pharmacologically active: clinical trials and the pharmaceutical industryMichael Kahn, Michael Gastrow
Mini Reviews in Medicinal Chemistry|October 9, 2002
Design, synthesis, and application of peptide secondary structure mimeticsMasakatsu Eguchi, Michael Kahn
Drug Discovery Today|October 26, 2005
Investigating Wnt signaling: a chemogenomic safariMichael McMillan, Michael Kahn
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 10, 2010
Targeting Wnt signaling: can we safely eradicate cancer stem cells?Fumi Takahashi-Yanaga, Michael Kahn
Advanced Drug Delivery Reviews|October 6, 2010
The Wnt signaling pathway in cellular proliferation and differentiation: A tale of two coactivatorsJia-Ling Teo, Michael Kahn
Cancer Science|July 1, 2014
Safely targeting cancer stem cells via selective catenin coactivator antagonismHeinz-Josef Lenz, Michael Kahn
Cell Biology and Toxicology|March 24, 2016
Kat3 coactivators in somatic stem cells and cancer stem cells: biological roles, evolution, and pharmacologic manipulationPaul D Thomas, Michael Kahn
Research and Reports in Biochemistry|November 14, 2015
The role of the Wnt signaling pathway in cancer stem cells: prospects for drug developmentYong-Mi Kim, Michael Kahn
Pageof 14